IRE1 Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies

Kolekcja
artykuły
Pobierz opis bibliograficzny

Opis

  • Tytuł: IRE1 Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies
  • Autor/Autorzy:
  • Nazwa czasopisma: Cancers
  • Rok: 2022
  • Tom: 14
  • Numer: 10
  • ISSN: 2072-6694
  • DOI: 10.3390/cancers14102526
  • Adres www:: https://www.mdpi.com/2072-6694/14/10/2526/pdf
  • Strony od-do: 1-17
  • Język: angielski
  • Abstrakt: Synthesis, folding, and structural maturation of proteins occur in the endoplasmic reticulum (ER). Accumulation of misfolded or unfolded proteins in the ER lumen contributes to the induction of ER stress and activation of the unfolded protein response (UPR) signaling pathway. Under ER stress, the UPR tries to maintain cellular homeostasis through different pathways, including the inositol-requiring enzyme 1 alpha (IRE1α)-dependent ones. IRE1α is located in an ER membrane, and it is evolutionarily the oldest UPR sensor. Activation of IRE1α via ER stress triggers the formation of the spliced form of XBP1 (XBP1s), which has been linked to a pro-survival effect in cancer cells. The role of IRE1α is critical for blood cancer cells, and it was found that the levels of IRE1α and XBP1s are elevated in various hematological malignancies. This review paper is focused on summarizing the latest knowledge about the role of IRE1α and on the assessment of the potential utility of IRE1α inhibitors in blood cancers.
  • Dyscyplina: nauki medyczne

MARC

  • 002 $a IRE1 Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies
  • 003 $a Wojciech Wiese (Autor)
  • 003 $b 0000-0002-0796-9717
  • 003 $a Natalia Siwecka (Autor)
  • 003 $b 0000-0002-0308-580X
  • 003 $a Adam Wawrzynkiewicz (Autor)
  • 003 $a Wioletta Rozpedek-Kamińska (Autor)
  • 003 $a Ireneusz Majsterek (Autor)
  • 003 $a EWA KUCHARSKA (Autor)
  • 003 $b 0000-0001-8757-6958
  • 004 $a Oryginalny artykuł naukowy
  • 005 $a Praca oryginalna
  • 006 $a Cancers
  • 008 $a 2022
  • 009 $a 14
  • 010 $a 10
  • 011 $a 2072-6694
  • 013 $a 10.3390/cancers14102526
  • 014 $a https://www.mdpi.com/2072-6694/14/10/2526/pdf
  • 015 $a 1-17
  • 017 $a angielski
  • 020 $a Synthesis, folding, and structural maturation of proteins occur in the endoplasmic reticulum (ER). Accumulation of misfolded or unfolded proteins in the ER lumen contributes to the induction of ER stress and activation of the unfolded protein response (UPR) signaling pathway. Under ER stress, the UPR tries to maintain cellular homeostasis through different pathways, including the inositol-requiring enzyme 1 alpha (IRE1α)-dependent ones. IRE1α is located in an ER membrane, and it is evolutionarily the oldest UPR sensor. Activation of IRE1α via ER stress triggers the formation of the spliced form of XBP1 (XBP1s), which has been linked to a pro-survival effect in cancer cells. The role of IRE1α is critical for blood cancer cells, and it was found that the levels of IRE1α and XBP1s are elevated in various hematological malignancies. This review paper is focused on summarizing the latest knowledge about the role of IRE1α and on the assessment of the potential utility of IRE1α inhibitors in blood cancers.
  • 022 $a blood cancer
  • 022 $a endoplasmic reticulum stress
  • 022 $a inositol-requiring enzyme 1 alpha (IRE alpha)
  • 022 $a leukemia
  • 022 $a lymphoma
  • 022 $a multiple myeloma
  • 022 $a unfolded protein response;
  • 022 $a X-box-binding protein 1 (XBP1)
  • 966 $a nauki medyczne
  • 985 $a Wydział Pedagogiczny
  • 985 $b Instytut Nauk o Wychowaniu

Dublin Core

Pliki

Kucharska IRE1α Inhibitors as a Promising Therapeutic Strategy in.pdf (928 KB)

  • Licencja: CC BY 4.0
  • Wersja tekstu: Ostateczna opublikowana
  • Dostępność: Publiczny